Kura Oncology officer files to sell 3,668 shares
Alpha Vantage · Kalkine Media · · AI-summarised by FinFlash
Kura Oncology officer Kathleen Ford filed a Form 144 signaling intent to sell 3,668 shares worth roughly $26,006, acquired via Performance Stock Units. The sale is expected on November 17, 2026, under a Rule 10b5-1 plan adopted earlier in the year. Ford has sold 17,616 shares over the preceding three months.
Understand the context
Published information may change. Summaries can contain errors; check the original source. Educational information only, not investment advice.